Key information

🔎 Fund Overview

Pulse Biosciences, Inc. is a bioelectric medicine company. The Company uses Nano-Pulse Stimulation technology, an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. It has developed CellFX System, which is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. The CellFX System is configured to accept a variety of handpieces or electrodes across a range of clinical applications. It has developed a cardiac ablation clamp for use in cardiac surgery and a cardiac ablation catheter for use in electrophysiology. The Company’s cardiac ablation clamp and cardiac ablation catheter both use the CellFX System to generate its proprietary pulses of electrical energy. Its surgical cardiac ablation clamp is designed for use by cardiac surgeons during the surgical treatment.